Showing results (11-20 of 3,079) with videos related to
Sort By:
Pageof 308
Drug Safety|May 29, 2019
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350Joan Fortuny, Alicia Gilsenan, Miguel Cainzos-Achirica, et al.Drug Safety|July 20, 2010
Safety of oseltamivir in pregnancy: a review of preclinical and clinical dataBarbara Donner, Viswanathan Niranjan, Gerhard HoffmannDrug Safety|July 20, 2010
Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysisSten Olsson, Shanthi N Pal, Andy Stergachis, et al.Drug Safety|August 13, 2010
Lactic acidosis induced by metformin: incidence, management and preventionJean-Daniel LalauDrug Safety|September 4, 2010
Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the USPamela L Smithburger, Sandra L Kane-Gill, Amy L SeybertDrug Safety|November 17, 2010
Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the NetherlandsNancy Broos, Eugène P van Puijenbroek, Kees van GrootheestDrug Safety|November 17, 2010
An experimental investigation of masking in the US FDA adverse event reporting system databaseHsin-wei Wang, Alan M Hochberg, Ronald K Pearson, et al.Drug Safety|November 5, 2010
Effects of proton pump inhibitors on adverse gastrointestinal events in patients receiving clopidogrel: systematic review and meta-analysisChun Shing Kwok, Ramanpreet Singh Nijjar, Yoon Kong LokeDrug Safety|February 22, 2011
A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancerGiannis Mountzios, Kostas N SyrigosDrug Safety|February 22, 2011
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilanceJohn-Joseph Borg, George Aislaitner, Michal Pirozynski, et al.Pageof 308